Avanos Medical, Inc.
Avanos Medical, Inc. (AVNS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AVNS · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
4
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Avanos Medical, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
AVNS insider buying and selling by quarter
AVNS insider selling · AVNS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · AVNS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
AVNS executive sell shares · AVNS board member insider trading · AVNS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 22, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 4,228 | $104K | Form 4 |
| Apr 22, 2026 | Delgado Sigfrido SVP, Operations | Other | 4,264 | $105K | Form 4 |
| Apr 14, 2026 | Pacitti David CEO | Other | 21,194 | $308K | Form 4 |
| Mar 13, 2026 | Hurley John Joseph PAO | Award | 2,211 | — | Form 4 |
| Mar 13, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Award | 29,481 | — | Form 4 |
| Mar 13, 2026 | Pacitti David CEO | Award | 101,341 | — | Form 4 |
| Mar 13, 2026 | Delgado Sigfrido SVP, Operations | Award | 15,886 | — | Form 4 |
| Mar 9, 2026 | Hurley John Joseph PAO | Other | 226 | $3K | Form 4 |
| Mar 9, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 1,119 | $15K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Option | 919 | $13K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 321 | $4K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 144 | $2K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 211 | $3K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Option | 5,907 | $81K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 2,356 | $32K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 1,057 | $15K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 2,041 | $28K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 13,834 | $152K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 100 | $1K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 761 | $8K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 305 | $3K | Form 4 |
| Sep 5, 2025 | Hurley John Joseph PAO | Other | 345 | $4K | Form 4 |
| Aug 13, 2025 | BLACKFORD GARY Director | Purchase | 20,000 | $220K | Form 4 |
| Aug 13, 2025 | BLACKFORD GARY Director | Purchase | 40,000 | $440K | Form 4 |
| May 13, 2025 | Greiner Michael Former Interim CEO | Other | 19,771 | $246K | Form 4 |
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Apr 22
Shares
4,228
Price
$24.64
Value
$104K
Delgado Sigfrido
SVP, Operations
Date
Apr 22
Shares
4,264
Price
$24.64
Value
$105K
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 13
Shares
29,481
Price
—
Value
—
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 9
Shares
1,119
Price
$13.29
Value
$15K
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 6
Shares
5,907
Price
$13.79
Value
$81K
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 6
Shares
2,356
Price
$13.79
Value
$32K
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 6
Shares
1,057
Price
$13.79
Value
$15K
Galovan Scott Michael
SVP, Chief Financial Officer
Date
Mar 6
Shares
2,041
Price
$13.79
Value
$28K
Holbrook Kerr
SVP, Chief Commercial Officer
Date
Nov 18
Shares
13,834
Price
$11.00
Value
$152K
Holbrook Kerr
SVP, Chief Commercial Officer
Date
Nov 18
Shares
100
Price
$11.01
Value
$1K
Holbrook Kerr
SVP, Chief Commercial Officer
Date
Nov 18
Shares
761
Price
$11.01
Value
$8K
Holbrook Kerr
SVP, Chief Commercial Officer
Date
Nov 18
Shares
305
Price
$11.02
Value
$3K
Greiner Michael
Former Interim CEO
Date
May 13
Shares
19,771
Price
$12.43
Value
$246K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AVNS insider trading
AVNS insider trades
Avanos Medical, Inc. (AVNS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Galovan Scott Michael (SVP, Chief Financial Officer), Hurley John Joseph (PAO), Holbrook Kerr (SVP, Chief Commercial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. AVNS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Avanos Medical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AVNS insider trading · 5 questionsThe insiders of Avanos Medical, Inc. (AVNS) include executives and directors such as Galovan Scott Michael (SVP, Chief Financial Officer), Hurley John Joseph (PAO), Holbrook Kerr (SVP, Chief Commercial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026